Researchers have built a cancer vaccine that recruits the immune memory left behind by COVID-19 infection and vaccination, and tested it in mice.
The work was published in Nature Communications on July 27 by a team from the company Celloram Inc., University Hospitals, and Case Western Reserve University. The platform is called PROTEXI. The paper's own title states that the results were obtained in mice.
